Nuzenio

Rituximab

Rituximab news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Incidence of Hypersensitivity Reactions With Rapid Rituximab Infusions for Classical Hematology Indications - jhoponline.comjhoponline.com · Fri, 07 Aug 2026 18:08:59 GMTRituximab Matches Ocrelizumab in Head-to-Head MS Trial - The American Journal of Managed CareThe American Journal of Managed Care · Fri, 07 Aug 2026 17:52:29 GMTEpcoritamab Combo Shows Sustained Remissions in Follicular Lymphoma - CancerNetworkCancerNetwork · Fri, 07 Aug 2026 15:39:51 GMTLong-term complete remission following treatment with polatuzumab vedotin, rituximab, and bendamustine in a patient with mantle cell lymphoma relapsing after CAR-T cell therapy: a case report - Sage JournalsSage Journals · Wed, 05 Aug 2026 11:57:51 GMTFDA Clears Rituximab Biosimilar, Expanding Options for B-Cell Malignancies - Targeted OncologyTargeted Oncology · Tue, 04 Aug 2026 20:10:58 GMTFDA Approves Rituximab Biosimilar Commercialized in US by Fresenius Kabi - Contract PharmaContract Pharma · Tue, 04 Aug 2026 18:43:31 GMTRituximab Biosimilars Show Similar 6-Month Outcomes to Originator in ANCA-Associated Vasculitis - MedscapeMedscape · Tue, 04 Aug 2026 14:40:15 GMTRituximab May Improve Outcomes in Severe CNS-Involved Sjögren Disease - Rheumatology AdvisorRheumatology Advisor · Tue, 04 Aug 2026 04:00:00 GMT

Timeline

Fri, 07 Aug 2026 18:08:59 GMTIncidence of Hypersensitivity Reactions With Rapid Rituximab Infusions for Classical Hematology Indications - jhoponline.com
Fri, 07 Aug 2026 17:52:29 GMTRituximab Matches Ocrelizumab in Head-to-Head MS Trial - The American Journal of Managed Care
Fri, 07 Aug 2026 15:39:51 GMTEpcoritamab Combo Shows Sustained Remissions in Follicular Lymphoma - CancerNetwork
Wed, 05 Aug 2026 11:57:51 GMTLong-term complete remission following treatment with polatuzumab vedotin, rituximab, and bendamustine in a patient with mantle cell lymphoma relapsing after CAR-T cell therapy: a case report - Sage Journals
Tue, 04 Aug 2026 20:10:58 GMTFDA Clears Rituximab Biosimilar, Expanding Options for B-Cell Malignancies - Targeted Oncology
Tue, 04 Aug 2026 18:43:31 GMTFDA Approves Rituximab Biosimilar Commercialized in US by Fresenius Kabi - Contract Pharma

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Rituximab.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.